Madrigal Pharmaceuticals MDGL
NASDAQ MDGL
$457.96 -9.58 (-2.05%)
At close: Oct 21, 2026 · 4:00 PM EDT

Madrigal Pharmaceuticals (MDGL) Notes Payables (2015)

Updated

Madrigal Pharmaceuticals (MDGL) reported Notes Payables of $48.6 million for Q4 2015.

Analysis

Madrigal Pharmaceuticals (MDGL) Notes Payables (2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Madrigal Pharmaceuticals 13.33 Bn 9.58 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 48.60 Mn
API Access

Madrigal Pharmaceuticals Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=MDGL&period=max&api_key=YOUR_API_KEY